Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 | Portage Biotech's Director Steven Mintz proposes to sell 7577 Shares, with a total value of approximately $121,245.19.

Form 144 | Portage Biotech's Director Gregory Bailey proposes to sell 70,000 shares, with a total value of approximately $1.24 Million.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form S-8 - Securities to be offered to employees in employee benefit plans

Form CORRESP - Correspondence

Form F-1 - Registration statement for certain foreign private issuers

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

CORRESP [Cover] - Correspondence

CORRESP [Cover] - Correspondence

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]